Photo by rachitank from unsplash
Oral isotretinoin is a highly effective drug for severe acne but with ongoing serious safety concerns, and we are cautiously reminded by the Medicines and Healthcare products Regulatory Authority (MHRA)… Click to show full abstract
Oral isotretinoin is a highly effective drug for severe acne but with ongoing serious safety concerns, and we are cautiously reminded by the Medicines and Healthcare products Regulatory Authority (MHRA) to prescribe this drug within licence. We review the National Institute for Health and Care Excellence (NICE) recommendations for considering referral of acne to specialist care and propose some improvements. This may help manage patient expectations of treatment, ensure only appropriate cases are seen in secondary care, and help prescribers remain within the isotretinoin product licence.
Journal Title: Clinical and experimental dermatology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!